RxDoctor Payments Data

Alanna Castaldo

Physician Assistant · Amherst, NYNPI 1063777670

Payments from drug & device makers

$11,838in general payments, 2019–2025

Across 698 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • MDD US Operations, LLC$1K
  • AstraZeneca$526
  • Neurocrine Biosciences, Inc.$488
  • Amgen$469
  • plus $6K from 50 others

What the payments were for

  • Speaking & faculty fees$1251%
  • Food & beverage$11,61298%
  • Education$1011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie113$1,742
Teva Pharmaceuticals USA, Inc.102$1,450
MDD US Operations, LLC47$1,414
AstraZeneca29$526
Neurocrine Biosciences, Inc.29$488
Amgen(2 entities)23$469
Novartis31$431
UCB, Inc.21$410
Acadia Pharmaceuticals Inc50$372
Kyowa Kirin, Inc.15$286
Avanir Pharmaceuticals, Inc.12$284
Lundbeck LLC17$283
Pfizer14$256
SK Life Science, Inc.10$245
Amneal Pharmaceuticals LLC10$238
Johnson & Johnson10$237
Averitas Pharma Inc.7$184
GRT US Holding, Inc.17$182
GE HealthCare19$169
Axsome Therapeutics, Inc.7$148
Tanabe Pharma America, Inc.8$148
Alnylam Pharmaceuticals Inc.9$144
Adamas Pharmaceuticals, Inc.6$140
Biohaven Pharmaceutical Holding Company Ltd.13$129
Merz Pharmaceuticals, LLC6$126
Avion Pharmaceuticals9$124
Supernus Pharmaceuticals, Inc.7$121
Catalyst Pharmaceuticals, Inc.4$102
Upsher-smith Laboratories LLC5$95
Otsuka America Pharmaceutical, Inc.4$71
Mallinckrodt Hospital Products Inc.4$69
Greenwich Biosciences, Inc.4$64
Ipsen Biopharmaceuticals, Inc3$63
TG Therapeutics, Inc.3$58
Takeda Pharmaceuticals U.S.A., Inc.2$46
Banner Life Sciences, LLC3$39
Jazz Pharmaceuticals Inc.2$39
CSL Behring2$38
Bristol Myers Squibb1$35
Impel Pharmaceuticals Inc.2$33
Intrabio Inc1$32
Lilly USA, LLC2$30
Livanova USA, Inc.2$27
Biohaven Pharmaceuticals, Inc.1$26
Biogen1$24
Kedrion Biopharma, Inc.1$22
Sarepta Therapeutics, Inc.1$21
Sunovion Pharmaceuticals Inc.1$20
Azurity Pharmaceuticals, Inc.1$20
Sanofi1$18
Genentech USA, Inc.1$18
Otter Pharmaceuticals, LLC1$17
Bausch Health US, LLC1$17
Eisai Inc.1$17
Octapharma USA, Inc.1$15
Acorda Therapeutics, Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,838 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$29,739
Medicare patients
141
Services billed
830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine11$71,067
Droxidopa15$66,781
Nurtec OdtRimegepant Sulfate13$19,001
Rasagiline Mesylate53$16,857
UbrelvyUbrogepant13$15,105
Aimovig AutoinjectorErenumab-Aooe16$14,478
FycompaPerampanel11$14,478
Carbidopa-LevodopaCarbidopa/Levodopa292$12,765
Lamotrigine668$10,727
LamictalLamotrigine12$9,665
Gabapentin398$6,799
Levetiracetam158$5,427
Oxcarbazepine95$4,906
Primidone155$4,897
Entacapone32$4,261

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$1,450$71,06711 claims
PfizerNurtec Odt$256$19,00113 claims
AbbVieUbrelvy$1,742$15,10513 claims
Eisai Inc.Fycompa$17$14,47811 claims
Upsher-smith Laboratories LLCTopiramate$95$1,458101 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Amherst

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →